carnitine has been researched along with angiotensin ii in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angelini, A; Calvani, M; Dalla Libera, L; Della Barbera, M; Dona, M; Gobbo, V; Mosconi, L; Peluso, G; Ravara, B; Sandri, M; Vescovo, G | 1 |
Chao, HH; Chen, CH; Cheng, TH; Lin, JW; Liu, JC; Wong, KL | 1 |
Blanca, AJ; Fortuño, A; González-Roncero, FM; Mate, A; Miguel-Carrasco, JL; Revilla, E; Ruiz-Armenta, MV; Vázquez, CM; Zambrano, S | 1 |
3 other study(ies) available for carnitine and angiotensin ii
Article | Year |
---|---|
L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Carnitine; Caspase 3; Caspase 9; Caspases; Cell Nucleus; Cells, Cultured; Cytoprotection; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Glucose Transporter Type 4; Heart Failure; In Situ Nick-End Labeling; Liver Function Tests; Male; Monocrotaline; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Muscular Disorders, Atrophic; Myosin Heavy Chains; Protein Isoforms; Rats; Rats, Sprague-Dawley; Sphingolipids; Staurosporine; Tumor Necrosis Factor-alpha | 2002 |
L-Carnitine attenuates angiotensin II-induced proliferation of cardiac fibroblasts: role of NADPH oxidase inhibition and decreased sphingosine-1-phosphate generation.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiotonic Agents; Carnitine; Cell Proliferation; Cells, Cultured; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Gene Expression Regulation; Heart; Lysophospholipids; Myocardium; NADPH Oxidases; Osmolar Concentration; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Sphingosine; Transcription Factor AP-1 | 2010 |
l-Carnitine ameliorates the oxidative stress response to angiotensin II by modulating NADPH oxidase through a reduction in protein kinase c activity and NF-κB translocation to the nucleus.
Topics: Angiotensin II; Animals; Carnitine; Hypertension; NADPH Oxidases; NF-kappa B; Oxidative Stress; Protein Kinase C | 2017 |